K-pop

"Small-Label Sensation" Risenne to Make a Comeback with a New Song on November 3

A Long-Running Hit Following a Successful Comeback on the Music Charts New Song Released Four Months After "Pretty Girl"

KIM HYUNSIK
2026-09-18 18:15:03
[Edaily Starin, Reporter KIM HYUNSIK ] Girl group Lisenne (Woni, Liv, Minami, May, Jenna) has confirmed their comeback date.
Lissene (Photo courtesy of The Muse Entertainment)
According to their agency, The Muse Entertainment, on the 18th, Lissene will release a new song on November 3 and kick off their comeback promotions. Further details regarding the comeback will be revealed at a later date.
Launched by The Muse Entertainment in March 2024, Lisenne surged in popularity as a top girl group after achieving a chart resurgence on music charts in the first half of this year. Their original variety content, released on their YouTube channel, served as the catalyst for this resurgence. Their song “LOVE ATTACK,” released in August 2024, reached No. 1 on major charts, including Melon, and continues to hold the top spot on several charts.
It has been about four months since Lisenne—regarded as the new standard-bearer of the “small-label idol legend”—released a new album and made a comeback. Last July, Lisenne promoted with “Pretty Girl,” a remake of the song of the same name originally released by KARA in December 2008. Building on the increased recognition from “Pretty Girl,” they have continued their momentum by securing spots at the very top of the charts with “Deja Vu,” another track that has enjoyed a resurgence in popularity.

Economy

Corporation

IT·Science

Economy

Lisa Su Meets with Jeon Young-hyun for 3 Hours… “Broad Partnership” for Foundry Collaboration

Lisa Su, Chairwoman and CEO of AMD, concluded a meeting lasting over three hours with Jeon Young-hyun, President and CEO of SamsungElectronics and Vice Chairman in charge of the Device Solutions (DS) …
2026-10-07 20:35:47

Corporation

South Korea Enters the 160 Trillion Global Obesity Drug Market… HanmiGlobal Co., Ltd’s “Epe” Becomes First Domestically Developed Drug to Receive Approval

Epfeglenatide, developed by HanmiPharm, has received approval from the Ministry of Food and Drug Safety as the first domestically developed GLP-1-based obesity treatment. With this approval, Korea has…
2026-10-07 19:34:02

IT·Science

A Twist in the Story of the New Drug Rejected by Sanofi… Hanmi’s “Epe” Becomes the First Domestically Developed GLP-1 Weight-Loss Drug to Receive Approval

A new domestically developed drug has emerged to compete in the obesity treatment market, which is currently dominated by global pharmaceutical companies. With HanmiPharm’s efeglenatide receiving mark…
2026-10-07 18:22:02